1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid and Cancer of Pancreas

1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid has been researched along with Cancer of Pancreas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baird, SK; Burvenich, I; De Vos, F; Dumolyn, C; Scott, AM; Staelens, S; Van Steenkiste, M; Vervoort, L; Waegemans, E	1

Other Studies

1 other study(ies) available for 1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid and Cancer of Pancreas

Article	Year
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancer. Cancer biotherapy & radiopharmaceuticals, 2010, Volume: 25, Issue:2 Topics: Animals; Antibodies, Monoclonal; Drug Evaluation, Preclinical; Female; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Radioimmunoassay; Radiopharmaceuticals; Receptors, Vitronectin; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2010

Article

Year

Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancer.

Cancer biotherapy & radiopharmaceuticals, 2010, Volume: 25, Issue:2

Topics: Animals; Antibodies, Monoclonal; Drug Evaluation, Preclinical; Female; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Radioimmunoassay; Radiopharmaceuticals; Receptors, Vitronectin; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2010